{"id":22912,"date":"2017-03-10T16:31:53","date_gmt":"2017-03-10T16:31:53","guid":{"rendered":"https:\/\/corporate.webfactory.ferring.tech\/?p=22912"},"modified":"2021-05-10T18:13:11","modified_gmt":"2021-05-10T17:13:11","slug":"ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction","status":"publish","type":"post","link":"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/","title":{"rendered":"Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction"},"content":{"rendered":"[spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;]\n<h2 style=\"color: #0088ce\">Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction<\/h2>\n[\/spb_boxed_content] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;]\n<h3 style=\"color: #0088ce\">Saint-Prex, Switzerland \u2013 09 March 2017 \u2013<\/h3>\n<p>Ferring Pharmaceuticals today announced an agreement with Apricus Biosciences, Inc. (Nasdaq:APRI), granting Ferring global assets and rights, excluding the U.S., related to Apricus\u2019 Vitaros\u00ae (alprostadil cream). Vitaros is an on-demand topical cream indicated for the treatment of patients with erectile dysfunction.<\/p>\n<p>Ferring is Apricus\u2019 existing commercialisation partner for Vitaros in Latin America and parts of Europe and Asia. Following an agreed handover period, Ferring will be responsible for managing all Vitaros-related activities outside of the U.S. with existing Vitaros commercialisation partners.\u00a0Apricus will retain its Vitaros rights in the U.S.<\/p>\n<p>&#8220;Urology is a key therapeutic area for Ferring,&#8221; said Michel Pettigrew, President of the Executive Board and COO, Ferring Pharmaceuticals. \u201cThis agreement strengthens our existing portfolio and reinforces Ferring\u2019s commitment to improving the quality of life of patients with a broad range of urological conditions.\u201d<\/p>\n<p>&#8211; ENDS &#8211;<\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;]\n<h3 style=\"color: #0088ce\">About Ferring Pharmaceuticals<\/h3>\n<p>Headquartered in Saint-Prex, Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.<\/p>\n<p>For further information on Ferring or its products, visit <a href=\"https:\/\/www.ferring.com\/\">www.ferring.com<\/a>.<\/p>\n<p>*Vitaros\u00ae is a registered trademark of NexMed International Limited, and will be assigned to Ferring B.V. worldwide, excluding the United States.\u00a0 Such trademark is registered in certain countries throughout the world and pending registration in the United States.<\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;]\n<h3 style=\"color: #0088ce\">For more information, please contact<\/h3>\n<p>Ferring Pharmaceuticals<br \/>\n<strong>Lindsey Rodger<\/strong><br \/>\nTel. +41 58 451 40 23<br \/>\n<a href=\"mailto:lindsey.rodger@ferring.com\">lindsey.rodger@ferring.com<\/a><\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_row element_name=&#8221;Row&#8221; wrap_type=&#8221;content-width&#8221; parallax_image_height=&#8221;content-height&#8221; parallax_image_movement=&#8221;fixed&#8221; parallax_image_speed=&#8221;0.5&#8243; bg_video_loop=&#8221;yes&#8221; parallax_video_height=&#8221;window-height&#8221; parallax_video_overlay=&#8221;none&#8221; row_overlay_opacity=&#8221;0&#8243; row_col_pos=&#8221;default&#8221; minimize_row=&#8221;no&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_button button_text=&#8221;READ MORE PRESS RELEASES&#8221; button_size=&#8221;standard&#8221; button_colour=&#8221;accent&#8221; button_type=&#8221;standard&#8221; rounded=&#8221;no&#8221; button_dropshadow=&#8221;no&#8221; button_link=&#8221;\/media\/press-releases\/&#8221; button_target=&#8221;_self&#8221; align=&#8221;center&#8221; animation=&#8221;none&#8221; animation_delay=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [\/spb_row]\n","protected":false},"excerpt":{"rendered":"<p>[spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction [\/spb_boxed_content] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] Saint-Prex, Switzerland \u2013 09 March 2017 \u2013 Ferring Pharmaceuticals today announced an agreement with Apricus Biosciences, Inc. (Nasdaq:APRI), granting Ferring global [&hellip;]<\/p>\n","protected":false},"author":2410,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[244],"tags":[],"class_list":["post-22912","post","type-post","status-publish","format-standard","hentry","category-press-release-2017"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.3 (Yoast SEO v23.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction - Ferring Global<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction\" \/>\n<meta property=\"og:description\" content=\"[spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction [\/spb_boxed_content] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] Saint-Prex, Switzerland \u2013 09 March 2017 \u2013 Ferring Pharmaceuticals today announced an agreement with Apricus Biosciences, Inc. (Nasdaq:APRI), granting Ferring global [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/\" \/>\n<meta property=\"og:site_name\" content=\"Ferring Global\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-03-10T16:31:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-10T17:13:11+00:00\" \/>\n<meta name=\"author\" content=\"pulse\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ferring\" \/>\n<meta name=\"twitter:site\" content=\"@ferring\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"pulse\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/\"},\"author\":{\"name\":\"pulse\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d\"},\"headline\":\"Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction\",\"datePublished\":\"2017-03-10T16:31:53+00:00\",\"dateModified\":\"2021-05-10T17:13:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/\"},\"wordCount\":542,\"publisher\":{\"@id\":\"https:\/\/www.ferring.com\/#organization\"},\"articleSection\":[\"PRESS RELEASE 2017\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/\",\"url\":\"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/\",\"name\":\"Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction - Ferring Global\",\"isPartOf\":{\"@id\":\"https:\/\/www.ferring.com\/#website\"},\"datePublished\":\"2017-03-10T16:31:53+00:00\",\"dateModified\":\"2021-05-10T17:13:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ferring.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ferring.com\/#website\",\"url\":\"https:\/\/www.ferring.com\/\",\"name\":\"Ferring Pharmaceuticals\",\"description\":\"Helping people live better lives\",\"publisher\":{\"@id\":\"https:\/\/www.ferring.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ferring.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ferring.com\/#organization\",\"name\":\"Ferring\",\"url\":\"https:\/\/www.ferring.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png\",\"contentUrl\":\"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png\",\"width\":236,\"height\":154,\"caption\":\"Ferring\"},\"image\":{\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\",\"https:\/\/x.com\/ferring\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d\",\"name\":\"pulse\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g\",\"caption\":\"pulse\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction - Ferring Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/","og_locale":"en_US","og_type":"article","og_title":"Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction","og_description":"[spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction [\/spb_boxed_content] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] Saint-Prex, Switzerland \u2013 09 March 2017 \u2013 Ferring Pharmaceuticals today announced an agreement with Apricus Biosciences, Inc. (Nasdaq:APRI), granting Ferring global [&hellip;]","og_url":"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/","og_site_name":"Ferring Global","article_publisher":"https:\/\/www.facebook.com\/ferringpharmaceuticals\/","article_published_time":"2017-03-10T16:31:53+00:00","article_modified_time":"2021-05-10T17:13:11+00:00","author":"pulse","twitter_card":"summary_large_image","twitter_creator":"@ferring","twitter_site":"@ferring","twitter_misc":{"Written by":"pulse","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/#article","isPartOf":{"@id":"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/"},"author":{"name":"pulse","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d"},"headline":"Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction","datePublished":"2017-03-10T16:31:53+00:00","dateModified":"2021-05-10T17:13:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/"},"wordCount":542,"publisher":{"@id":"https:\/\/www.ferring.com\/#organization"},"articleSection":["PRESS RELEASE 2017"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/","url":"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/","name":"Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction - Ferring Global","isPartOf":{"@id":"https:\/\/www.ferring.com\/#website"},"datePublished":"2017-03-10T16:31:53+00:00","dateModified":"2021-05-10T17:13:11+00:00","breadcrumb":{"@id":"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ferring.com\/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ferring.com\/"},{"@type":"ListItem","position":2,"name":"Ferring acquires ex-U.S. assets and rights for Vitaros\u00ae (alprostadil cream), Apricus\u2019 on-demand topical cream for erectile dysfunction"}]},{"@type":"WebSite","@id":"https:\/\/www.ferring.com\/#website","url":"https:\/\/www.ferring.com\/","name":"Ferring Pharmaceuticals","description":"Helping people live better lives","publisher":{"@id":"https:\/\/www.ferring.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ferring.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ferring.com\/#organization","name":"Ferring","url":"https:\/\/www.ferring.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/","url":"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png","contentUrl":"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png","width":236,"height":154,"caption":"Ferring"},"image":{"@id":"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ferringpharmaceuticals\/","https:\/\/x.com\/ferring"]},{"@type":"Person","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d","name":"pulse","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g","caption":"pulse"}}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/22912"}],"collection":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/users\/2410"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/comments?post=22912"}],"version-history":[{"count":0,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/22912\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/media?parent=22912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/categories?post=22912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/tags?post=22912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}